Proteomika Overview
- Founded
-
2002
- Status
-
Acquired/Merged
- Employees
-
5
- Latest Deal Type
-
M&A
Proteomika General Information
Description
Provider of biomarkers designed for non-invasive diagnosis of complex diseases. The company's biomarkers are diagnostic assays that offers individualized optimization of treatment regimes by measuring drug response, such as drug bioavailability and immunogenicity.
Contact Information
Primary Office
- Parque Tecnológico de Bizkaia 504
- 48160 Derio
- Spain
+34 944 00 00 00
Proteomika Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Merger/Acquisition | 01-Jan-2015 | Completed | Generating Revenue | |||
| 1. Seed Round | 10-Apr-2004 | Completed | Startup |
Proteomika Patents
Proteomika Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20110053793-A1 | Methods and products for identifying strains of bacteria | Inactive | 21-Dec-2007 | 000000000000 | |
| EP-2235534-A1 | Methods and products for identifying strains of bacteria | Inactive | 21-Dec-2007 | 000000000000 |
Proteomika Executive Team (3)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Laureano Simón Ph.D | Chief Executive Officer |
Proteomika Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Proteomika Former Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Seed Capital Bizkaia | Venture Capital | Minority | 000 0000 | 000000 0 |